Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2  (03-2003)

Period of time： 2003年2期

Publisher： Elsevier

Founded in： 1983

Total resources： 45

ISSN： 1078-1439

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2

Menu

Overview of contents

By Prout G.R. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 43-44

Elsevier

Abstract Access to resources Recommend Favorite

Immunotherapy of urologic tumors - principles and progress

By Broghammer E.L., Ratliff T.L. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 45-56

Elsevier

Abstract Access to resources Recommend Favorite

Identification of two genes differentially expressed upon different spatial configuration of the MGH-U3 human bladder cancer cells

By Champetier S., Fradet Y., Bachvarov D. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 57-61

Elsevier

Abstract Access to resources Recommend Favorite

p21 gene codon 31 polymorphism is associated with bladder cancer

By Chen W.-C., Wu H.-C., Hsu C.-D., Chen H.-Y., Tsai F.-J. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 63-66

Elsevier

Abstract Access to resources Recommend Favorite

Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder

By Morgan B.E., Salup R., Morgan M.B. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 67-72

Elsevier

Abstract Access to resources Recommend Favorite

Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer

By Lehrer S., Stone N.N., Droller M.J., Stock R.G. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 73-76

Elsevier

Abstract Access to resources Recommend Favorite

Phase II trial of interleukin 2, interferon , and 5-fluorouracil in metastatic renal cell cancer - a cytokine working group study.

By Dutcher J., Logan T., Gordon M., Sosman J., Weiss G., Margolin K., Plasse T., Mier J., Lotze M., Clark J., Atkins M. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 83-84

Elsevier

Abstract Access to resources Recommend Favorite

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M., Vaughan M., Webb A., Johnston S., Savage P., Eisen T., Bates S., Morre J., Ahern R., Gore M. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 83-83

Elsevier

Abstract Access to resources Recommend Favorite

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil.

By Negrier S., Caty A., Lesimple T., J-Y D., Escudier B., J-F R., Viens P., Gomez F. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 84-84

Elsevier

Abstract Access to resources Recommend Favorite

Preoperative use of 3D volume rendering to demonstrate renal tumors and renal anatomy.

By Coll D., Herts B., Davros W., Uzzo R., Novick A. in (2002)

Urologic Oncology: Seminars and Original Investigations,volume 7,issue 2 , Vol. 7, Iss. 2, 2002-03 , pp. 85-85

Elsevier

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 14 item(s)